Decoding PharmEasy’s latest down round logic

The proposed rights issue, at a 90% valuation cut, makes one thing clear: it’s the investors who are calling the shots here.

July 07, 20234 min
0
Decoding PharmEasy’s latest down round logic

You may also like

Internet
Story image

Fintech Hala’s new millions

One of the largest-ever funding rounds among the Middle East startups, Carrefour’s latest exits and other updates from the week.

Health
Story image

How Kerala brought its infant mortality rate to a historic low

Decades of investment in health and social infrastructure went into getting the southern state’s infant mortality rate down to 5 deaths per 1,000 live births—far lower than the national average of 25.

Internet
Story image

Peak XV Partners should win the record outcome test with Pine Labs

Finally, this question will be answered. Who has returned the most amount of capital on any venture investment in India in the last two decades?